Spectaire (SPEC) S-4 23 Jun 23 Registration of securities issued in business combination transactions Financial data

Cover Page

Cover Page	3 Months Ended
	Mar. 31, 2023
Document Information [Line Items]
Document Type	S-4
Amendment Flag	false
Entity Registrant Name	Perception Capital Corp. II
Entity Central Index Key	0001844149
Entity Filer Category	Non-accelerated Filer
Entity Incorporation, State or Country Code	E9
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash	$ 48,857	$ 4,730	$ 818,833
Prepaid expenses	77,179	107,179	342,364
Deferred offering costs	14,532
Total current assets	140,568	111,909	1,161,197
Prepaid expenses - noncurrent			107,084
Investments held in Trust Account	26,071,412	25,517,987	233,452,747
Total Assets	26,211,980	25,629,896	234,721,028
Current liabilities:
Accounts payable	755,466	783,055	10,035
Accounts payable — related party	35,425	104,808	49,182
Accrued expenses	3,714,663	1,906,825	126,644
Accrued expense — related party	15,570	10,977
Accrued offering costs	224,235	224,235	231,235
Convertible promissory notes — related party	941,578	221,631
Forward purchase units	4,020,000
Total current liabilities	9,706,937	3,251,531	417,096
Deferred underwriting fee payable	5,635,000	8,050,000	8,050,000
Total Liabilities	15,341,937	11,301,531	8,467,096
Commitments and Contingencies
Class A ordinary shares subject to possible redemption	25,971,412	25,417,987	233,450,000
Shareholders' Deficit:
Preference shares, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding
Accumulated deficit	(15,101,944)	(11,090,197)	(7,196,643)
Total shareholders' deficit	(15,101,369)	(11,089,622)	(7,196,068)
Total Liabilities and Shareholders' Deficit	26,211,980	25,629,896	234,721,028
Class B Ordinary Shares
Shareholders' Deficit:
Ordinary shares	$ 575	$ 575	$ 575

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement [Line Items]
Preference shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preference shares, shares authorized	5,000,000	5,000,000	5,000,000
Preference shares, shares issued	0	0	0
Preference shares, shares outstanding	0	0	0
Class A Ordinary Shares
Statement [Line Items]
Temporary equity, shares subject to possible redemption	2,457,892	2,457,892	23,000,000
Temporary equity ordinary shares, per share | $ / shares	$ 10.57	$ 10.34	$ 10.15
Ordinary shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	500,000,000	500,000,000	500,000,000
Ordinary shares, shares issued	0	0	0
Ordinary shares, shares outstanding	0	0	0
Class B Ordinary Shares
Statement [Line Items]
Preference shares, shares issued		0
Preference shares, shares outstanding			0
Ordinary shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	50,000,000	50,000,000	50,000,000
Ordinary shares, shares issued	5,750,000	5,750,000	5,750,000
Ordinary shares, shares outstanding	5,750,000	5,750,000	5,750,000

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		11 Months Ended	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2022
Statement [Line Items]
Operating and formation costs	$ 2,111,800	$ 508,376	$ 316,021	$ 3,794,176
Loss from operations	(2,111,800)	(508,376)	(316,021)	(3,794,176)
Interest and dividend income on investments held in Trust Account	258,478	18,197	2,747	2,030,383
Change in fair value of forward purchase units	(190,000)
Net Loss	(2,043,322)	(490,179)	$ (313,274)	(1,763,793)
Class A Ordinary Shares
Statement [Line Items]
Net Loss	$ (611,882)	$ (392,143)		$ (1,360,510)
Weighted average shares outstanding, Basic	2,457,892	23,000,000	4,011,628	19,398,096
Weighted average shares outstanding, Diluted	2,457,892	23,000,000	4,011,628	19,398,096
Net income (loss) per share, Basic	$ (0.25)	$ (0.02)	$ (0.03)	$ (0.07)
Net Income (loss) per share, Diluted	$ (0.25)	$ (0.02)	$ (0.03)	$ (0.07)
Class B Ordinary Shares
Statement [Line Items]
Net Loss	$ (1,431,440)	$ (98,036)		$ (403,283)
Weighted average shares outstanding, Basic	5,750,000	5,750,000	5,072,674	5,750,000
Weighted average shares outstanding, Diluted	5,750,000	5,750,000	5,072,674	5,750,000
Net income (loss) per share, Basic	$ (0.25)	$ (0.02)	$ (0.03)	$ (0.07)
Net Income (loss) per share, Diluted	$ (0.25)	$ (0.02)	$ (0.03)	$ (0.07)

CONDENSED STATEMENTS OF OPERA_2

CONDENSED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($)	1 Months Ended
	Aug. 31, 2021	Oct. 28, 2022	Sep. 29, 2022
Statement [Line Items]
Ordinary shares, shares outstanding		23,264,839	28,750,000
Sponsor
Statement [Line Items]
Number Of Shares Surrendered	1,437,500
Stock issued during the period for services value	$ 0
Ordinary shares, shares outstanding	5,750,000

CONDENSED STATEMENTS OF CHANGES

CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)	3 Months Ended		11 Months Ended	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Statement [Line Items]
Beginning Balance	$ (11,089,622)	$ (7,196,068)	$ 0	$ (7,196,068)
Issuance of Class B ordinary shares to Sponsor			25,000
Proceeds allocate to public warrants, net of offering costs			9,072,568
Sale of 10,050,000 private placement warrants to Sponsor, net of offering costs			10,014,058
Net loss	(2,043,322)	(490,179)	(313,274)	(1,763,793)
Remeasurement of Class A common stock to redemption amount	(553,425)		(25,994,420)	(2,129,761)
Initial measurement of forward purchase units	(3,830,000)
Reduction of deferred underwriting fee payable	2,415,000
Ending Balance	(15,101,369)	(7,686,247)	(7,196,068)	(11,089,622)	$ (7,196,068)
Class A Ordinary Shares
Statement [Line Items]
Net loss	(611,882)	(392,143)		(1,360,510)	(138,342)
Class B Ordinary Shares
Statement [Line Items]
Net loss	(1,431,440)	(98,036)		(403,283)	(174,932)
Common Stock | Class A Ordinary Shares
Statement [Line Items]
Beginning Balance		$ 0	$ 0	$ 0
Beginning Balance, Shares		0	0	0
Ending Balance			$ 0		$ 0
Ending Balance, Shares			0		0
Common Stock | Class B Ordinary Shares
Statement [Line Items]
Beginning Balance	$ 575	$ 575	$ 0	$ 575
Beginning Balance, Shares	5,750,000	5,750,000	0	5,750,000
Issuance of Class B ordinary shares to Sponsor			$ 575
Issuance of Class B ordinary shares to Sponsor, Shares			5,750,000
Ending Balance	$ 575	$ 575	$ 575	$ 575	$ 575
Ending Balance, Shares	5,750,000	5,750,000	5,750,000	5,750,000	5,750,000
Additional Paid-in Capital
Statement [Line Items]
Beginning Balance		$ 0	$ 0	$ 0
Issuance of Class B ordinary shares to Sponsor			24,425
Proceeds allocate to public warrants, net of offering costs			9,072,568
Sale of 10,050,000 private placement warrants to Sponsor, net of offering costs			10,014,058
Remeasurement of Class A common stock to redemption amount			(19,111,051)
Ending Balance			0		$ 0
Accumulated Deficit
Statement [Line Items]
Beginning Balance	$ (11,090,197)	(7,196,643)	0	(7,196,643)
Net loss	(2,043,322)	(490,179)	(313,274)	(1,763,793)
Remeasurement of Class A common stock to redemption amount	(553,425)		(6,883,369)	(2,129,761)
Initial measurement of forward purchase units	(3,830,000)
Reduction of deferred underwriting fee payable	2,415,000
Ending Balance	$ (15,101,944)	$ (7,686,822)	$ (7,196,643)	$ (11,090,197)	$ (7,196,643)

CONDENSED STATEMENTS OF CHANG_2

CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) (Parenthetical)	11 Months Ended
	Dec. 31, 2021 shares
Private Placement | Warrants
Statement [Line Items]
Number of sale units	10,050,000

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended		11 Months Ended	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2022
Cash Flows from Operating Activities:
Net Loss	$ (2,043,322)	$ (490,179)	$ (313,274)	$ (1,763,793)
Adjustments to reconcile net loss to net cash used in operating activities:
Formation costs paid by Sponsor in exchange for Class B ordinary shares			11,770
Interest and dividend income on investments held in Trust Account	(258,478)	(18,197)	(2,747)	(2,030,383)
Change in fair value of forward purchase units	190,000
Changes in operating assets and liabilities:
Prepaid expenses	30,000	45,034	(449,448)	342,269
Deferred offering costs	(14,533)
Accounts payable	(27,588)	12,305	10,035	773,020
Accounts payable — related party	(69,383)	(49,182)	49,182	55,626
Accrued expenses	1,807,838	193,294	126,644	1,784,158
Accrued expense — related party	4,593	25,799
Net cash used in operating activities	(380,873)	(281,126)	(567,838)	(839,103)
Cash Flows from Investing Activities:
Cash withdrawn from Trust Account for payment to redeeming shareholders				210,161,774
Cash deposited into Trust Account	(294,947)		(233,450,000)	(196,631)
Net cash used in investing activities	(294,947)		(233,450,000)	209,965,143
Cash Flows from Financing Activities:
Repayment of promissory note - related party			(223,765)
Proceeds from convertible promissory notes — related party				221,631
Proceeds from sale of private placement warrants			10,050,000
Proceeds from initial public offering gross			225,400,000
Payment to redeeming shareholders				(210,161,774)
Proceeds from convertible promissory notes - related party	719,947		223,765
Payment of offering costs		(7,000)	(613,329)
Net cash provided by (used in) financing activities	719,947	(7,000)	234,836,671	(209,940,143)
Net Change in Cash	44,127	(288,126)	818,833	(814,103)
Cash — Beginning of period	4,730	818,833		818,833
Cash — End of period	48,857	$ 530,707	818,833	4,730
Supplemental disclosures of non-cash investing and financing activities:
Accretion of Class A ordinary shares subject to redemption to redemption value			25,994,420	$ 2,129,761
Deferred underwriting fee payable			8,050,000
Offering costs paid in exchange for issuance of Class B ordinary shares to Sponsor			13,230
Offering costs included in accrued offering costs			$ 231,235
Accretion of Class A ordinary shares subject to redemption value	553,425
Reduction of deferred underwriting fee payable	2,415,000
Initial measurement of forward purchase units	$ 3,830,000

Description of Organization, Bu

Description of Organization, Business Operations and Liquidity	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Description of Organization, Business Operations and Liquidity	NOTE 1. DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND LIQUIDITY Perception Capital Corp. II (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on January 21, 2021. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of March 31, 2023, the Company had not commenced any operations. All activity for the period from January 21, 2021 (inception) through March 31, 2023 relates to the Company’s formation and initial public offering (“Initial Public Offering”), and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. The Company will generate non-operating The registration statement for the Company’s Initial Public Offering was declared effective on October 27, 2021. On November 1, 2021, the Company consummated the Initial Public Offering of 23,000,000 units, (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), including 3,000,000 Units issued pursuant to the exercise of the underwriters’ over-allotment option in full, generating gross proceeds of $230,000,000, which is discussed in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 10,050,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Perception Capital Partners II LLC (the “Sponsor”), including 1,050,000 Private Placement Warrants issued pursuant to the exercise of the underwriters’ over-allotment option in full, generating gross proceeds of $10,050,000, which is described in Note 4. Following the closing of the Initial Public Offering, an amount of $233,450,000 ($10.15 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), and will be invested only in U.S. government treasury obligations with maturities of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 Transaction costs related to the issuances described above amounted to $13,617,198, consisting of $4,600,000 of cash underwriting fees, $8,050,000 of deferred underwriting fees and $967,198 of other offering costs. On March 23, 2023, the underwriters agreed to reduce their rights to the portion of the fee payable by the Company for deferred underwriting commissions, which is discussed in Note 7. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more target businesses that together have an aggregate fair market value of at least 80% of the value of the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Company will provide its holders of Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.15 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares subject to redemption will be recorded at redemption value and classified as temporary equity upon the completion of the Initial Offering in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, Distinguishing Liabilities from Equity The Company will proceed with a Business Combination only if, in the event that the Company seeks shareholder approval, a majority of the shares voted are voted in favor of the Business Combination (see Note 10 for subsequent amendment to charter). If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or don’t vote at all. Notwithstanding the above, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor has agreed to waive (i) redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination, (ii) redemption rights with respect to any Founder Shares and Public Shares held by it in connection with a shareholder vote to amend the Company’s Amended and Restated Memorandum and Articles of Association to modify the substance or timing of the Company’s obligation to allow redemption in connection with an initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete an initial Business Combination by May 1, 2023. Subsequent to the period, the Company extended to the initial public offering date to November 1, 2023 (See Note 10), or with respect to any other provision relating to shareholders’ rights or pre-initial or any extended period of time that the Company may have to consummate an initial Business Combination. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination by November 1, 2023. The Company will have until November 1, 2023 to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than 10 business days thereafter, redeem 100% of the Public Shares, at a per-share The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.15 per Public Share or (2) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Amendment to Certificate of Incorporation On October 28, 2022, the Company held an extraordinary general meeting (the “general meeting”), at which holders of 23,264,839 ordinary shares, comprised of 17,514,839 Class A ordinary shares, par value $0.0001 per share (“Class A ordinary shares”), and 5,750,000 Class B ordinary shares, par value $0.0001 per share (“Class B ordinary shares,” and together with the Class A ordinary shares, the “ordinary shares”), were present in person or by proxy, representing approximately 80.9% of the voting power of the 28,750,000 issued and outstanding ordinary shares of the company, comprised of 23,000,000 Class A ordinary shares and 5,750,000 Class B ordinary shares, entitled to vote at the general meeting at the close of business on September 29, 2022, which was the record date (the “record date”) for the general meeting. Shareholders of record as of the close of business on the record date are referred to herein as “shareholders.” On October 28, 2022, the company filed with the Cayman Islands Registrar of Companies an amendment to the amended and restated memorandum and articles of association of the company (the “charter amendment”). The charter amendment extended the date by which the company must (1) consummate a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination (the “initial business combination”), (2) cease its operations except for the purpose of winding up if it fails to complete such initial business combination, and (3) redeem all of the Class A ordinary shares included as part of the units sold in its initial public offering from November 1, 2022, to May 1, 2023 (the “October 28, 2022 charter extension”). Subsequent to the period, the Company extended to the initial public offering date to November 1, 2023 (See Note 10). In connection with the October 28, 2022 charter extension, a total of 159 shareholders elected to redeem an aggregate of 20,542,108 Class A ordinary shares, representing approximately 89.3% of the issued and outstanding Class A ordinary shares. As a result, $210,161,773.71 was paid out of the company’s trust account in connection with the redemptions, representing a redemption price per Class A ordinary share of approximately $10.23. On October 31, 2022, the Company issued a convertible promissory note in the aggregate principal amount of up to $720,000 (the “extension loan”) to its sponsor, Perception Capital Partners II LLC, a Delaware limited liability company (the “sponsor”). The total borrowings on the note as of March 31, 2023 is $491,578. The extension loan was issued in connection with certain payments to be made by the sponsor into the trust account of the company pursuant to the company’s amended and restated certificate of incorporation, to provide the company with an extension of the date by which it must consummate an initial business combination from November 1, 2022, to May 1, 2023. See Note 6 for further discussion on the convertible promissory note. Subsequent to the period, the Company extended to the initial public offering date to November 1, 2023 (See Note 10). Business Combination Agreement On January 16, 2023, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Perception Spectaire Merger Sub Corp., a Delaware corporation and a direct wholly owned subsidiary of the Company (“Merger Sub”), and Spectaire Inc., a Delaware corporation (“Spectaire”). Details regarding the merger can be found in the Company’s January 17, 2023 Form 8-K (i) prior to the effective time of the Business Combination (the “Effective Time”), the aggregate amount of each outstanding convertible promissory note of Spectaire, including all outstanding principal and interest accrued but unpaid thereon, will convert into shares of common stock, par value $0.0001 per share, of Spectaire (“Spectaire Common Stock”), and each share of the Series Seed Preferred Stock, par value $0.0001 per share, of Spectaire will convert into one share of Spectaire Common Stock (such conversions, the “Spectaire Security Conversion”); (ii) at the Effective Time (after giving effect to the Spectaire Security Conversion): (a) each share of Spectaire Common Stock (other than shares of Spectaire Common Stock subject to Spectaire Options and Spectaire RSUs (each as defined below), Spectaire Restricted Shares (as defined below), treasury stock and dissenting shares) will convert into the right to receive its pro rata portion (on a fully diluted basis) of the Net Merger Consideration and the Earnout Shares (as defined below); (b) each outstanding option to purchase Spectaire Common Stock (“Spectaire Option”) will be converted into (x) an option to purchase, upon substantially the same terms and conditions, a whole number of shares of PCCT (“Perception Capital Corp. II) Common Stock (rounded down to the nearest whole share) equal to (1) the number of shares of Spectaire Common Stock subject to such Spectaire Option as of immediately prior to the Effective Time multiplied by (2) the Exchange Ratio (as defined in the Merger Agreement) and (y) the right to receive its pro rata portion of the Earnout Shares; (c) each outstanding restricted stock unit relating to Spectaire Common Stock (“Spectaire RSU”) will be converted into (x) a restricted stock unit, upon substantially the same terms and conditions, relating to a whole number of shares of PCCT Common Stock (rounded down to the nearest whole share) equal to (1) the number of shares of Spectaire Common Stock subject to such Spectaire RSU as of immediately prior to the Effective Time multiplied by (2) the Exchange Ratio and (y) the right to receive its pro rata portion of the Earnout Shares; and (d) each outstanding award of restricted shares of Spectaire Common Stock subject to vesting conditions and/or a risk of forfeiture (“Spectaire Restricted Shares”) will be converted into (x) an award, upon substantially the same terms and conditions, of a whole number of restricted shares of PCCT Common Stock equal to (1) the number of shares of Spectaire Common Stock subject to such Spectaire Restricted Share as of immediately prior to the Effective Time multiplied by (2) the Exchange Ratio and (y) the right to receive its pro rata portion of the Earnout Shares. The number of Earnout Shares will be equal to 7,500,000 additional shares of PCCT Common Stock (as equitably adjusted for stock splits, reverse stock splits, stock dividends, reorganizations, recapitalizations, reclassifications, combinations, exchanges of shares or other like changes or transactions with respect to PCCT Common Stock occurring on or after the Closing). The Earnout Shares may be issued in three equal tranches upon the volume-weighted price per share of PCCT Common Stock equaling or exceeding $15.00, $20.00 or $25.00 for at least 20 trading days in any consecutive 30-day If, during the Earnout Period, (i) any liquidation, dissolution or winding up of Acquiror is initiated, (ii) any bankruptcy, dissolution or liquidation proceeding is instituted by or against Acquiror or (iii) Acquiror makes an assignment for the benefit of creditors or consents to the appointment of a custodian, receiver or trustee for all or substantial part of its assets or properties, then any Earnout Shares that have not been previously issued by Acquiror (whether or not previously earned) shall be deemed earned and due by Acquiror to the Eligible Company Equity holders. In connection with the business combination, the Company also entered into an agreement (the “Forward Purchase Agreement”) for an OTC Equity Forward Transaction (the “Forward Purchase Transaction”) with Meteora Special Opportunity Fund I, LLP, Meteora Capital Partners, LP, Meteora Select Trading Opportunities Master, LP (collectively the “Seller”). Pursuant to the terms of the Forward Purchase Agreement, the Seller intends, but is not obligated, to purchase up to a maximum of 2,457,892 of Perception’s Class A Ordinary Shares from holders (other than Perception or its affiliates) who have elected to redeem such shares in connection with the Business Combination. Purchases by Seller will be made through brokers in the open market after the redemption deadline in connection with the Business Combination at a price no higher than the redemption price to be paid by the Company in connection with the Business Combination. The Forward Purchase Agreement is within the scope of ASC 480-10 On March 31, 2023, in association with the Merger Agreement, the Company issued an unsecured promissory note to Spectaire, Inc. (“Spectaire Loan”), pursuant to which the Company may borrow up to an aggregate principal amount of $500,000. The promissory note was non-interest Going Concern As of March 31, 2023, the Company had $48,857 in cash held outside of the Trust Account and negative working capital of $9,566,369. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity will be satisfied through proceeds made available to the Company under Working Capital Loans (as defined in Note 6), Extension Loan (as defined in Note 6), and the Spectaire Loan (as defined in Note 1). While the Company expects to have sufficient access to additional sources of capital if necessary, there is no current commitment on the part of any financing source to provide additional capital and no assurances can be provided that such additional capital will ultimately be available if necessary. As noted in Note 10, subsequent to the reporting period the Company adopted an amendment to its amended and restatement memorandum and articles of association so that it will have until November 1, 2023 to complete a Business Combination. If a Business Combination is not consummated by November 1, 2023, there will be a mandatory liquidation and subsequent dissolution of the Company. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the accompanying financial statements are issued. There is no assurance that the Company’s plans to raise additional capital (to the extent ultimately necessary) or to consummate a Business Combination will be successful or successful within the Combination Period (including any extended period of time as described above). The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty. Risks and Uncertainties In addition to the risks noted above under Going Concern, the company is also subject to the following: Management continues to evaluate the impact of the COVID-19 Additionally, as a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations and/or ability to consummate a Business Combination are not yet determinable. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. We deposit substantial funds in financial institutions and may, from time to time, maintain cash balances at such financial institutions in excess of the Federal Deposit Insurance Corporation limit. Recently, there has been significant volatility and instability among banks and financial institutions and on March 10, 2023, Silicon Valley Bank, at SVB, was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation, or the FDIC, as receiver, and for a period of time, customers of the bank did not have access to their funds and there was uncertainty as to when, if at all, customers would have access to funds in excess of the FDIC insured amounts. The Company held deposits at SVB at the time of its closure but the deposits were under the FDIC limit and no losses were incurred. Going forward, should one or more of the financial institutions at which our deposits are maintained fail, there is no guarantee as to the extent that we would recover the funds deposited, whether through Federal Deposit Insurance Corporation coverage or otherwise, or the timing o	NOTE 1. DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND LIQUIDITY Perception Capital Corp. II (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on January 21, 2021. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of December 31, 2022, the Company had not commenced any operations. All activity for the period from January 21, 2021 (inception) through December 31, 2022 relates to the Company’s formation and initial public offering (“Initial Public Offering”), and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. On January 16, 2023, the company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Perception Spectaire Merger Sub Corp., a Delaware corporation and a direct wholly owned subsidiary of PCCT (“Merger Sub”), and Spectaire Inc., a Delaware corporation (“Spectaire”). See Note 9 for further details. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating The registration statement for the Company’s Initial Public Offering was declared effective on October 27, 2021. On November 1, 2021, the Company consummated the Initial Public Offering of 23,000,000 units, (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), including 3,000,000 Units issued pursuant to the exercise of the underwriters’ over-allotment option in full, generating gross proceeds of $230,000,000, which is discussed in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 10,050,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Perception Capital Partners II LLC (the “Sponsor”), including 1,050,000 Private Placement Warrants issued pursuant to the exercise of the underwriters’ over-allotment option in full, generating gross proceeds of $10,050,000, which is described in Note 4. Following the closing of the Initial Public Offering, an amount of $233,450,000 ($10.15 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), and will be invested only in U.S. government treasury obligations with maturities of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 Transaction costs related to the issuances described above amounted to $13,617,198, consisting of $4,600,000 of cash underwriting fees, $8,050,000 of deferred underwriting fees and $967,198 of other offering costs. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more target businesses that together have an aggregate fair market value of at least 80% of the value of the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Company will provide its holders of Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.15 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares subject to redemption will be recorded at redemption value and classified as temporary equity upon the completion of the Initial Offering in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, Distinguishing Liabilities from Equity The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or don’t vote at all. Notwithstanding the above, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor has agreed to waive (i) redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination, (ii) redemption rights with respect to any Founder Shares and Public Shares held by it in connection with a shareholder vote to amend the Company’s Amended and Restated Memorandum and Articles of Association to modify the substance or timing of the Company’s obligation to allow redemption in connection with an initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete an initial Business Combination by May 1, 2023, or with respect to any other provision relating to shareholders’ rights or pre-initial The Company will have until May 1, 2023 to complete a Business Combination or receive shareholder approval for another extension (the “Combination Period”). If the Company is unable to complete a Business Combination or receive extension approval within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than 10 business days thereafter, redeem 100% of the Public Shares, at a per-share The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.15 per Public Share or (2) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Amendment to Certificate of Incorporation On October 28, 2022, the Company held an extraordinary general meeting (the “general meeting”), at which holders of 23,264,839 ordinary shares, comprised of 17,514,839 Class A ordinary shares, par value $0.0001 per share (“Class A ordinary shares”), and 5,750,000 Class B ordinary shares, par value $0.0001 per share (“Class B ordinary shares,” and together with the Class A ordinary shares, the “ordinary shares”), were present in person or by proxy, representing approximately 80.9% of the voting power of the 28,750,000 issued and outstanding ordinary shares of the company, comprised of 23,000,000 Class A ordinary shares and 5,750,000 Class B ordinary shares, entitled to vote at the general meeting at the close of business on September 29, 2022, which was the record date (the “record date”) for the general meeting. Shareholders of record as of the close of business on the record date are referred to herein as “shareholders.” On October 28, 2022, the company filed with the Cayman Islands Registrar of Companies an amendment to the amended and restated memorandum and articles of association of the company (the “charter amendment”). The charter amendment extended the date by which the company must (1) consummate a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination (the “initial business combination”), (2) cease its operations except for the purpose of winding up if it fails to complete such initial business combination, and (3) redeem all of the Class A ordinary shares included as part of the units sold in its initial public offering from November 1, 2022, to May 1, 2023 (the “charter extension”). In connection with the charter extension, a total of 159 shareholders have elected to redeem an aggregate of 20,542,108 Class A ordinary shares, representing approximately 89.3% of the issued and outstanding Class A ordinary shares. As a result, $210,161,773.71 was paid out of the company’s trust account in connection with the redemptions, representing a redemption price per Class A ordinary share of approximately $10.23. On October 31, 2022, the Company issued a convertible promissory note in the aggregate principal amount of up to $720,000 (the “extension loan”) to its sponsor, Perception Capital Partners II LLC, a Delaware limited liability company (the “sponsor”). The total borrowings on the note as of December 31, 2022 is $196,631. The extension loan was issued in connection with certain payments to be made by the sponsor into the trust account of the company pursuant to the company’s amended and restated certificate of incorporation, to provide the company with an extension of the date by which it must consummate an initial business combination from November 1, 2022, to May 1, 2023 (the “extension”) See Note 5 for further discussion on the convertible promissory note. Going Concern As of December 31, 2022, the Company had $4,730 in cash held outside of the Trust Account and negative working capital of $3,139,622. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity will be satisfied through the net proceeds from the private placement held outside of the Trust Account and proceeds made available to the Company under Working Capital Loans (as defined in Note 5). While the Company expects to have sufficient access to additional sources of capital if necessary, there is no current commitment on the part of any financing source to provide additional capital and no assurances can be provided that such additional capital will ultimately be available if necessary. The Company will have until May 1, 2023 to complete a Business Combination or receive shareholder approval for an extension. If a Business Combination is not consummated or an extension is not approved by May 1, 2023, there will be a mandatory liquidation and subsequent dissolution of the Company. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the accompanying financial statements are issued. There is no assurance that the Company’s plans to raise additional capital (to the extent ultimately necessary) or to consummate a Business Combination will be successful or successful within the Combination Period (including any extended period of time as described above). The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty. Risks and Uncertainties In addition to the risks noted above under Going Concern, the company is also subject to the following: Management continues to evaluate the impact of the COVID-19 Additionally, as a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations and/or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (the “Inflation Reduction Act”), which, among other things, imposes a 1% excise tax on any domestic corporation that repurchases its stock after December 31, 2022 (the “Excise Tax”). The Excise Tax is imposed on the fair market value of the repurchased stock, with certain exceptions. Because the combined company will be a Delaware corporation and the Company’s securities are expected to trade on Nasdaq following the Business Combination, the Company will be a “covered corporation” within the meaning of the Inflation Reduction Act following the Business Combination. While not free from doubt, absent any further guidance from Congress, the Excise Tax may apply to any redemptions of its Class A ordinary shares after December 31, 2022, including redemptions in connection with the Business Combination, unless an exemption is available.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates. Cash The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2023 and December 31, 2022. Investments Held in Trust Account As of March 31, 2023 and December 31, 2022, the assets held in the Trust Account were comprised of U.S. government securities, within the meaning set forth in Section 2(a) (16) of the Investment Company Act, with maturities of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are reported in the statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. As of March 31, 2023 and December 31, 2022, the assets held in the Trust Account were held in money market funds, which were invested in U.S. Treasury securities. The Company had $26,071,412 and $25,517,987 in investments held in the Trust Account as of March 31, 2023 and December 31, 2022, respectively. Warrants The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in non-cash Class A Ordinary Shares Subject to Possible Redemption All of the 23,000,000 Class A ordinary shares sold as part of the Units in the Initial Public Offering contain a redemption feature which allows for the redemption, at a price of $10.15 per share, of such Public Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Amended and Restated Memorandum and Articles of Association. In accordance with ASC 480-10-S99, Under ASC 480, the Company has elected to recognize changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid-in As of March 31, 2023 and December 31, 2022, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table: Gross proceeds $ 230,000,000 Less: Proceeds allocated to Public Warrants (9,637,000 ) Issuance costs allocated to Class A ordinary shares (12,907,420 ) Plus: Accretion of carrying value to redemption value 28,124,181 Initial Pre-Extension (210,161,774 ) Class A ordinary shares subject to possible redemption as of December 31, 2022 25,417,987 Plus: Remeasurement of carrying value to redemption value 553,425 Class A ordinary shares subject to possible redemption as of March 31, 2023 $ 25,971,412 Offering Costs associated with the Initial Public Offering The Company complies with the requirements of ASC Topic 340, Other Assets and Deferred Costs Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC Topic 740, Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Loss Per Ordinary Share Net loss per ordinary share is computed by dividing net loss by the weighted-average number of ordinary shares outstanding during the period. Accretion associated with the redeemable Class A ordinary shares is excluded from net loss per share as the redemption value approximates fair value. Therefore, the earnings per share calculation allocates income and losses shared pro rata between Class A and Class B ordinary shares. As a result, the calculated net loss per share is the same for Class A and Class B ordinary shares. The Company has not considered the effect of the Public Warrants and Private Placement Warrants to purchase an aggregate of 21,550,000 shares in the calculation of diluted net loss per share, since the exercise of the warrants are contingent upon the occurrence of future events. The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts): For the three months ended March 31, 2023 For the three months ended March 31, 2022 Class A Class B Class A Class B Basic and diluted net loss per share: Numerator: Net loss $ (611,882 ) $ (1,431,440 ) $ (392,143 ) $ (98,036 ) Denominator: Basic and diluted weighted average shares 2,457,892 5,750,000 23,000,000 5,750,000 Basic and diluted net loss per share $ (0.25 ) $ (0.25 ) $ (0.02 ) $ (0.02 ) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The Company applies ASC Topic 820, Fair Value Measurement reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. The carrying amounts reflected in the balance sheet for current assets and current liabilities approximate fair value due to their short-term nature. Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. See Note 9 for additional information on assets and liabilities measured at fair value. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates. Cash The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2022 and 2021. Investments Held in Trust Account As of December 31, 2022 and 2021, the assets held in the Trust Account were comprised of U.S. government securities, within the meaning set forth in Section 2(a) (16) of the Investment Company Act, with maturities of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are reported in the statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. As of December 31, 2022 and December 31, 2021, the assets held in the Trust Account were held in money market funds, which were invested in U.S. Treasury securities. The Company had $25,517,987 and $233,452,747 in investments held in the Trust Account as of December 31, 2022 and December 31, 2021, respectively. Warrants The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in non-cash Class A Ordinary Shares Subject to Possible Redemption All of the 23,000,000 Class A ordinary shares sold as part of the Units in the Initial Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Amended and Restated Memorandum and Articles of Association. In accordance with ASC 480-10-S99, Under ASC 480, the Company has elected to recognize changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid-in As of December 31, 2022 and December 31, 2021, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table: Gross proceeds $ 230,000,000 Less: Proceeds allocated to Public Warrants (9,637,000 ) Issuance costs allocated to Class A ordinary shares (12,907,420 ) Plus: Accretion of carrying value to redemption value 25,994,420 Class A ordinary shares subject to possible redemption as of December 31, 2021 233,450,000 Plus: Remeasurement of carrying value to redemption value 2,129,761 Initial Pre-Extension (210,161,774 ) Class A ordinary shares subject to possible redemption as of December 31, 2022 $ 25,417,987 Offering Costs associated with the Initial Public Offering The Company complies with the requirements of ASC Topic 340, Other Assets and Deferred Costs Expenses of Offering Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC Topic 740, Income Taxes (“ASC 740”). Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Loss Per Ordinary Share Net loss per ordinary share is computed by dividing net loss by the weighted-average number of ordinary shares outstanding during the period. Accretion associated with the redeemable Class A ordinary shares is excluded from net loss per share as the redemption value approximates fair value. Therefore, the earnings per share calculation allocates income and losses shared pro rata between Class A and Class B ordinary shares. As a result, the calculated net loss per share is the same for Class A and Class B ordinary shares. The Company has not considered the effect of the Public Warrants and Private Placement Warrants to purchase an aggregate of 21,550,000 shares in the calculation of diluted net loss per share, since the exercise of the warrants are contingent upon the occurrence of future events. The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts): For the Period Ended For the Period January 21, 2021 (Inception) through December 31, 2021 Class A Class B Class A Class B Basic and diluted net loss per share: Numerator: Net loss $ (1,360,510 ) $ (403,283 ) $ (138,342 ) $ (174,932 ) Denominator: Basic and diluted weighted average shares 19,398,096 5,750,000 4,011,628 5,072,674 Basic and diluted net loss per share $ (0.07 ) $ (0.07 ) $ (0.03 ) $ (0.03 ) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The Company applies ASC Topic 820, Fair Value Measurement The carrying amounts reflected in the balance sheet for current assets and current liabilities approximate fair value due to their short-term nature. Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. See Note 8 for additional information on assets and liabilities measured at fair value. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Equity [Abstract]
Initial Public Offering	NOTE 3. INITIAL PUBLIC OFFERING The registration statement for the Company’s Initial Public Offering was declared effective on October 27, 2021. On November 1, 2021, the Company consummated the Initial Public Offering of 23,000,000 Units, including 3,000,000 Units issued pursuant to the exercise of the underwriters’ over-allotment option in full, generating gross proceeds of $230,000,000. Each Unit consisted of one Class A ordinary share and one-half	NOTE 3. INITIAL PUBLIC OFFERING The registration statement for the Company’s Initial Public Offering was declared effective on October 27, 2021. On November 1, 2021, the Company consummated the Initial Public Offering of 23,000,000 Units, including 3,000,000 Units issued pursuant to the exercise of the underwriters’ over-allotment option in full, generating gross proceeds of $230,000,000. Each Unit consisted of one Class A ordinary share and one-half

Private Placement

Private Placement	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Equity [Abstract]
Private Placement	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 10,050,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant in a private placement to the Sponsor, including 1,050,000 Private Placement Warrants issued pursuant to the exercise of the underwriters’ over-allotment option in full, generating gross proceeds of $10,050,000. Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 10,050,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant in a private placement to the Sponsor, including 1,050,000 Private Placement Warrants issued pursuant to the exercise of the underwriters’ over-allotment option in full, generating gross proceeds of $10,050,000. Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

Accrued Expenses

Accrued Expenses	3 Months Ended
	Mar. 31, 2023
Accounts Payable And Accrued Liabilities Current [Abstract]
Accrued Expenses	NOTE 5. ACCRUED EXPENSES Accrued expenses consisted of the following at the dates indicated: March 31, December 31, Accrued expenses: Accrued legal fees $ 3,581,322 $ 1,905,225 Accrued accounting fees 133,341 1,600 Total accrued expenses $ 3,714,663 $ 1,906,825

Related Party Transactions

Related Party Transactions	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 6. RELATED PARTY TRANSACTIONS Founder Shares On January 25, 2021, the Sponsor paid an aggregate of $25,000 to cover certain expenses on behalf of the Company in exchange for the issuance of 7,187,500 Class B ordinary shares (the “Founder Shares”). In August 2021, the Sponsor surrendered 1,437,500 Class B ordinary shares for no consideration, resulting in an aggregate of 5,750,000 Class B ordinary shares outstanding (see Note 8). All share and per-share The Sponsor has agreed that, subject to certain limited exceptions, the Founder Shares will not be transferred, assigned, sold or released from escrow until the earlier of (a) one year after the completion of a Business Combination or (b) subsequent to a Business Combination (i) if last reported sale price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, 30-trading On April 7, 2021, the Sponsor transferred 30,000 Founder Shares to each of its three independent director nominees (the “Directors”) (or 90,000 Founder Shares in total) for cash consideration of approximately $0.003 per share (the “Purchase Price”). These awards are subject to ASC 718. Under ASC 718, compensation associated with equity-classified awards is measured at fair value upon the grant date. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founders Shares that ultimately vest multiplied times the grant date fair value per share of $2.08 (or a total of $187,489) (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares. Administrative Support Agreement The Company entered into an agreement, commencing on the effective date of the Initial Public Offering, to pay the Sponsor a total of up to $10,000 per month for office space, administrative and support services. Upon the completion of an initial Business Combination, the Company will cease paying these monthly fees. For the three months ended March 31, 2023 and 2022, $30,000 of administrative support expenses were incurred. As of March 31, 2023 and December 31, 2022, there was $20,000 outstanding under the Administrative Support Agreement. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the initial shareholders or an affiliate of the initial shareholders or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $2,500,000 of such Working Capital Loans may be convertible into warrants at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of March 31, 2023 and December 31, 2022, the outstanding amount of Working Capital Loans were $450,000 and $25,000, respectively, recorded in convertible promissory notes—related party on the condensed balance sheet. On October 31, 2022, the Company issued a convertible promissory note in the aggregate principal amount of up to $720,000 (the “extension loan”) to its sponsor, Perception Capital Partners II LLC, a Delaware limited liability company (the “sponsor”). The extension loan was issued in connection with certain payments to be made by the sponsor into the trust account of the company pursuant to the Company’s amended and restated certificate of incorporation, to provide the company with an extension of the date by which it must consummate an initial business combination from November 1, 2022 to May 1, 2023 (the “extension”). The contribution(s) and the extension loans will not bear any interest, and will be repayable by the company to the sponsor upon the earlier of (i) the date by which the company must complete an initial business combination and (ii) the consummation of an initial business combination. The extension loans may be settled, at the option of the sponsor, in whole warrants to purchase Class A ordinary shares of the company at a conversion price equal to $1.00 per warrant (the “extension loan warrants”). Each extension loan warrant will entitle the holder thereof to purchase one Class A ordinary share of the company at an exercise price of $11.50 per share, subject to certain adjustments. The extension loan warrants are identical to the warrants included in the units sold in the company’s initial public offering, except that, so long as they are held by the sponsor or its permitted transferees: (1) they will not be redeemable by the company; (2) they (including the Class A ordinary shares issuable upon exercise of the extension loan warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the sponsor until 30 days after the completion of the company’s initial business combination; (3) they may be exercised by the holders on a cashless basis; and (4) they (including the Class A ordinary shares issuable upon exercise of the extension loan warrants) are entitled to registration rights. The maturity date of the extension loans may be accelerated upon the occurrence of an “event of default” (as defined within the agreement). Any outstanding principal under the extension loans may be prepaid at any time by the company, at its election and without penalty, provided, however, that the sponsor shall have a right to first convert such principal balance of the extension loan upon notice of such prepayment. As of March 31, 2023 and December 31, 2022, $491,578 and $196,631, respectively, were outstanding under the extension loan recorded in convertible promissory notes—related party on the condensed balance sheet. Reimbursed Expenses—Related Party The Company’s Sponsor, directors and officers, or any of their respective affiliates, are reimbursed for any out-of-pocket	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On January 25, 2021, the Sponsor paid an aggregate of $25,000 to cover certain expenses on behalf of the Company in exchange for the issuance of 7,187,500 Class B ordinary shares (the “Founder Shares”). In August 2021, the Sponsor surrendered 1,437,500 Class B ordinary shares for no consideration, resulting in an aggregate of 5,750,000 Class B ordinary shares outstanding (see Note 7). All share and per-share The Sponsor has agreed that, subject to certain limited exceptions, the Founder Shares will not be transferred, assigned, sold or released from escrow until the earlier of (a) one year after the completion of a Business Combination or (b) subsequent to a Business Combination (i) if last reported sale price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, 30-trading On April 7, 2021, the Sponsor transferred 30,000 Founder Shares to each of its three independent director nominees (the “Directors”) (or 90,000 Founder Shares in total) for cash consideration of approximately $0.003 per share (the “Purchase Price”). These awards are subject to ASC 718. Under ASC 718, compensation associated with equity-classified awards is measured at fair value upon the grant date. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founders Shares that ultimately vest multiplied times the grant date fair value per share of $2.08 (or a total of $187,489) (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares. Promissory Notes — Related Party On January 25, 2021, the Company issued an unsecured promissory note to the sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The promissory note was non-interest Administrative Support Agreement The Company entered into an agreement, commencing on the effective date of the Initial Public Offering, to pay the Sponsor a total of up to $10,000 per month for office space, administrative and support services. Upon the completion of an initial Business Combination, the Company will cease paying these monthly fees. For the year ended December 31, 2022, $120,000 of administrative support expenses were incurred. For the period from January 21, 2021 (inception) through December 31, 2021, $20,000 of administrative support expenses were incurred. As of December 31, 2022 and December 31, 2021, $20,000 and $20,000 related to this agreement is recorded in accounts payable — related party on the balance sheet. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the initial shareholders or an affiliate of the initial shareholders or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $2,500,000 of such Working Capital Loans may be convertible into warrants at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of December 31, 2022, the outstanding amount of Working Capital Loans were $25,000. No Working Capital Loans were outstanding as of December 31, 2021. On October 31, 2022, the Company issued a convertible promissory note in the aggregate principal amount of up to $720,000 (the “extension loan”) to its sponsor, Perception Capital Partners II LLC, a Delaware limited liability company (the “sponsor”). The extension loan was issued in connection with certain payments to be made by the sponsor into the trust account of the company pursuant to the company’s amended and restated certificate of incorporation, to provide the company with an extension of the date by which it must consummate an initial business combination from November 1, 2022, to May 1, 2023 (the “extension”). The contribution(s) and the extension loans do not bear any interest and will be repayable by the company to the sponsor upon the earlier of (i) the date by which the company must complete an initial business combination and (ii) the consummation of an initial business combination. The extension loans may be settled, at the option of the sponsor, in whole warrants to purchase Class A ordinary shares of the company at a conversion price equal to $1.00 per warrant (the “extension loan warrants”). Each extension loan warrant will entitle the holder thereof to purchase one Class A ordinary share of the company at an exercise price of $11.50 per share, subject to certain adjustments. The extension loan warrants are identical to the warrants included in the units sold in the company’s initial public offering, except that, so long as they are held by the sponsor or its permitted transferees: (1) they will not be redeemable by the company; (2) they (including the Class A ordinary shares issuable upon exercise of the extension loan warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the sponsor until 30 days after the completion of the company’s initial business combination; (3) they may be exercised by the holders on a cashless basis; and (4) they (including the Class A ordinary shares issuable upon exercise of the extension loan warrants) are entitled to registration rights. The maturity date of the extension loans may be accelerated upon the occurrence of an “event of default” (as defined within the agreement). Any outstanding principal under the extension loans may be prepaid at any time by the company, at its election and without penalty, provided, however, that the sponsor shall have a right to first convert such principal balance of the extension loan upon notice of such prepayment. As of December 31, 2022, $196,631 is outstanding under the extension loan. Reimbursed Expenses — Related Party The Company’s Sponsor, directors and officers, or any of their respective affiliates, are reimbursed for any out-of-pocket

Commitments

Commitments	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Commitments And Contingencies Disclosure [Abstract]
Commitments	NOTE 7. COMMITMENTS Registration and Shareholder Rights Agreement The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement signed prior to the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement Simultaneously with the Initial Public Offering, the underwriters fully exercised the over-allotment option to purchase an additional 3,000,000 Units at an offering price of $10.00 per Unit for an aggregate purchase price of $30,000,000. The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $4,600,000 in the aggregate, upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $8,050,000 in the aggregate, as adjusted as described below, will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. On March 23, 2023, the underwriters agreed to waive their rights to the portion of the fee payable by the Company for deferred underwriting commissions. The waived fee amount of $2,415,000 was recorded as an increase to accumulated deficit on the Company’s balance sheet.	NOTE 6. COMMITMENTS Registration and Shareholder Rights Agreement The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement signed prior to the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up Underwriting Agreement Simultaneously with the Initial Public Offering, the underwriters fully exercised the over-allotment option to purchase an additional 3,000,000 Units at an offering price of $10.00 per Unit for an aggregate purchase price of $30,000,000. The underwriters were paid a cash underwriting discount of $0.20 per Unit, or $4,600,000 in the aggregate, upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $8,050,000 in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Shareholders' Equity

Shareholders' Equity	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Stockholders Equity Note [Abstract]
Shareholders' Equity	NOTE 8. SHAREHOLDERS’ EQUITY Preference shares Class A ordinary shares Class B ordinary shares On January 25, 2021, the Sponsor paid an aggregate of $25,000 to cover certain expenses on behalf of the Company in exchange for the issuance of 7,187,500 Class B ordinary shares. In August 2021, the Sponsor surrendered 1,437,500 Class B ordinary shares for no consideration, resulting in an aggregate of 5,750,000 Class B ordinary shares outstanding. Class A ordinary shareholders and Class B ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and vote together as a single class, except as required by law; provided that, prior to an initial Business Combination, holders of the Company’s Class B ordinary shares will have the right to appoint all of the Company’s directors and remove members of the board of directors for any reason, and holders of the Company’s Class A ordinary shares will not be entitled to vote on the appointment of directors during such time. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of an initial Business Combination, or earlier at the option of the holder, on a one-for-one sub-divisions, as-converted Warrants The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a current prospectus relating thereto is current, subject to the satisfying the obligations described below with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue Class A ordinary shares upon exercise of a warrant unless Class A ordinary shares issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any warrant. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial business combination, the Company will use the commercially reasonable efforts to file with the SEC a registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use the commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the initial business combination and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed; provided that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at the option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, the Company will not be required to file or maintain in effect a registration statement. Redemption of Public Warrants • in whole and not in part; • at a price of $0.01 per warrant; • upon not less than 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the reported last reported sale price of the Class A ordinary shares for any 20 trading days within a 30-trading The Company will not redeem the warrants for cash unless a registration statement under the Securities Act covering the issuance of the shares of Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day The Private Placement Warrants are identical to the Public Warrants except that: (1) they will not be redeemable; (2) they (including the Class A ordinary shares issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of the initial business combination, as described below; (3) they may be exercised by the holders on a cashless basis; and (4) they (including the ordinary shares issuable upon exercise of these warrants) are entitled to registration rights. The Company accounts for the 21,550,000 warrants issued in connection with the Initial Public Offering (including 11,500,000 Public Warrants and 10,050,000 Private Placement Warrants) in accordance with the guidance contained in ASC 815. Such guidance provides that the warrants described above are not precluded from equity classification. Equity-classified contracts are initially measured at fair value (or allocated value). Subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity.	NOTE 7. SHAREHOLDERS’ EQUITY Preference shares Class A ordinary shares — Class B ordinary shares — On January 25, 2021, the Sponsor paid an aggregate of $25,000 to cover certain expenses on behalf of the Company in exchange for the issuance of 7,187,500 Class B ordinary shares. In August 2021, the Sponsor surrendered 1,437,500 Class B ordinary shares for no consideration, resulting in an aggregate of 5,750,000 Class A ordinary shareholders and Class B ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and vote together as a single class, except as required by law; provided that, prior to an initial Business Combination, holders of the Company’s Class B ordinary shares will have the right to appoint all of the Company’s directors and remove members of the board of directors for any reason, and holders of the Company’s Class A ordinary shares will not be entitled to vote on the appointment of directors during such time. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of an initial Business Combination, or earlier at the option of the holder, on a one-for-one sub-divisions, as-converted Warrants — The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a current prospectus relating thereto is current, subject to the satisfying the obligations described below with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue Class A ordinary shares upon exercise of a warrant unless Class A ordinary shares issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any warrant. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial business combination, the Company will use the commercially reasonable efforts to file with the SEC a registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use the commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the initial business combination and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed; provided that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at the option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, the Company will not be required to file or maintain in effect a registration statement. Redemption of Public Warrants • in whole and not in part; • at a price of $0.01 per warrant; • upon not less than 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the reported last reported sale price of the Class A ordinary shares for any 20 trading days within a 30-trading The Company will not redeem the warrants for cash unless a registration statement under the Securities Act covering the issuance of the shares of Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day The Private Placement Warrants are identical to the Public Warrants except that: (1) they will not be redeemable; (2) they (including the Class A ordinary shares issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of the initial business combination, as described below; (3) they may be exercised by the holders on a cashless basis; and (4) they (including the ordinary shares issuable upon exercise of these warrants) are entitled to registration rights. The Company accounts for the 21,550,000 warrants issued in connection with the Initial Public Offering (including 11,500,000 Public Warrants and 10,050,000 Private Placement Warrants) in accordance with the guidance contained in ASC 815. Such guidance provides that the warrants described above are not precluded from equity classification. Equity-classified contracts are initially measured at fair value (or allocated value). Subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity.

Fair Value Measurements

Fair Value Measurements	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 9. FAIR VALUE MEASUREMENTS The following table presents information about the Company’s financial assets that are measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Amount at Level 1 Level 2 Level 3 March 31, 2023 Assets Investments held in Trust Account: U.S. Treasury Securities $ 26,071,412 $ 26,071,412 $ — $ — Liabilities Forward purchase units $ 4,020,000 $ — $ — $ 4,020,000 December 31, 2022 Assets Investments held in Trust Account: U.S. Treasury Securities $ 25,517,987 $ 25,517,987 $ — $ — The Company utilizes a Black-Scholes model to value the forward purchase units at each reporting period, with changes in fair value recognized in the statement of operations. The estimated fair value of the forward purchase units liability is determined using Level 3 inputs. Inherent in a Black-Scholes model are assumptions related to expected share-price volatility, expected life, risk-free rate and dividend yield. The Company estimates the volatility which is based on a weighted-average of the expected pre-merger pre-merger zero-coupon The following table provides the significant inputs to the model for the fair value of the forward purchase units: At (inception) At March 31, 2023 Equity value $ 10.75 $ 10.63 Strike Price $ 11.93 $ 11.93 Remaining Life (years) 1.80 1.59 Risk-free rate 4.70 % 4.60 % Volatility 52.90 % 56.90 % The following table presents the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value: Level 3 Fair value as of January 14, 2023 (inception) $ 3,830,000 Change in fair value of forward purchase units 190,000 Fair value as of March 31, 2023 $ 4,020,000 The Company recognized a loss in connection with changes in the fair value of the forward purchase units liability of $190,000 within changes in fair value of forward purchase units in the Statements of Operations for the for the three months ended March 31, 2023.	NOTE 8. FAIR VALUE MEASUREMENTS The following table presents information about the Company’s financial assets that are measured at fair value on a recurring basis as of December 31, 2022 and December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Amount at Fair Value Level 1 Level 2 Level 3 December 31, 2022 Assets Investments held in Trust Account: U.S. Treasury Securities $ 25,517,987 $ 25,517,987 $ — $ — December 31, 2021 Assets Investments held in Trust Account: U.S. Treasury Securities $ 233,452,747 $ 233,452,747 $ — $ —

Subsequent Events

Subsequent Events	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	NOTE 10. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than noted below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. On April 10, 2023, the company issued an amended and restated convertible promissory note (the “A&R extension loan”) to the sponsor, which amended and restated the original extension loan in its entirety to, among other things, increase the aggregate principal amount available thereunder from $720,000 to $1,200,000, the effectiveness of which is conditioned upon the approval of the company’s shareholders of the proposal to amend the company’s amended and restated memorandum and articles of association to extend the date by which the company must consummate an initial business combination from May 1, 2023 to November 1, 2023. Pursuant to the A&R extension loan, the sponsor has agreed to continue its monthly contributions of $0.04 for each Class A ordinary share of the company, par value $0.0001 per share (“Class A ordinary shares”), then outstanding until the earlier of (i) the date of the extraordinary general meeting held in connection with the shareholder vote to approve an initial business combination and (ii) the aggregate advances under the A&R extension loan totaling $1,200,000. On April 27, 2023, the company filed with the Cayman Islands Registrar of Companies an amendment to the charter (the “charter amendment”) to further extend the date by which the company must either (1) consummate a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination (the “initial business combination”) or (2) (i) cease its operations except for the purpose of winding up and (ii) redeem all outstanding Class A ordinary shares included as part of the units sold in its initial public offering, from May 1, 2023 to November 1, 2023 (the “extension amendment”). Shareholders approved, by special resolution, the proposal to amend the charter to eliminate the limitation that the company may not redeem Class A ordinary shares to the extent that such redemption would result in the company having net tangible assets of less than $5,000,001 (the “redemption limitation”) in order to allow the company to redeem Class A ordinary shares irrespective of whether such redemption would exceed the redemption limitation (the “redemption limitation amendment” and, together with the extension amendment, the “proposed charter amendments”). In connection with the vote to approve the proposed charter amendments, 17 shareholders properly exercised their right to redeem an aggregate of 376,977 Class A ordinary shares, at a redemption price of approximately $10.70 per share, for an aggregate redemption amount of approximately $4,033,654. On April 3, 2023, and April 19, 2023, the Company drew down $200,000, and $300,000, respectively on the promissory note in association with the Merger Agreement (see Note 1). On April 3, 2023, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that, for the previous 30 consecutive business days, the Market Value of Listed Securities (“MVLS”) for the Class A ordinary shares, was below the $50 million minimum MVLS requirement for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Rule”). The letter is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on Nasdaq. In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company will have 180 calendar days, or until October 2, 2023 (the “MVLS Compliance Date”), to regain compliance with the MVLS Rule. To regain compliance with the MVLS Rule, the MVLS for the Class A ordinary shares must be at least $50 million for a minimum of 10 consecutive business days at any time during this 180-day On May 5, 2023, the Company received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that, for the previous 30 consecutive business days, the Market Value of Publicly Held Shares (“MVPHS”) for the Class A ordinary shares of the Company, par value $0.0001 per share (“Class A Ordinary Shares”), was below the $15 million minimum MVPHS requirement for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(3)(C) (the “MVPHS Rule”). The Letter is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on Nasdaq. In accordance with Nasdaq Listing Rule 5810(c)(3)(D), the Company will have 180 calendar days, or until November 1, 2023 (the “MVPHS Compliance Date”), to regain compliance with the MVPHS Rule. To regain compliance with the MVPHS Rule, the MVPHS for the Class A ordinary shares must be at least $15 million for a minimum of 10 consecutive business days at any time during this 180-day	NOTE 9. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than noted below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. On January 3, 2023, February 1, 2023, and March 1, 2023, the Company drew down an additional $98,316 on the extension loan, $294,947 in total (see Note 5). On January 16, 2023, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Perception Spectaire Merger Sub Corp., a Delaware corporation and a direct wholly owned subsidiary of the Company (“Merger Sub”), and Spectaire Inc., a Delaware corporation (“Spectaire”). Details regarding the merger can be found in the Company’s January 18, 2023 Form 8-K Form 10-Q On February 28, 2023, March 6, 2023 and March 22, 2023, the Company drew down an additional $225,000, $150,000 and $50,000, respectively on the working capital loan (see Note 5). On March 23, 2023, the Company and Jefferies, as representative of the IPO Underwriters, entered into the pursuant to that certain first amendment agreement to the underwriting agreement between Jefferies, as representative of the IPO Underwriters, and the Company, pursuant to which the Company and Jefferies agreed that the deferred underwriting discount will be payable only to Jefferies, individually and not as representative and for the accounts of the IPO Underwriters, after such other IPO Underwriters waived or indicated to PCCT they will waive their entitlement to the payment of any deferred underwriting discount, thereby reducing the amount of such deferred underwriting discount to $5,635,000 (the “Deferred Discount”) to be paid as follows: (a) if there is at least $25,000,000 of (i) available funds in the Trust Account, plus (ii) amounts received by the Company in connection with equity purchase agreements prior to or substantially concurrently with the Closing, minus (iii) amounts payable in connection with the Redemption, minus (iv) amounts payable pursuant to the Forward Purchase Agreement, minus (v) all fees incurred by the Company and Spectaire for outside advisors in connection with the Business Combination (the “Closing Surviving Corporation Cash”), the Deferred Discount will be due to Jefferies at the Closing; and (b) if there is less than $25,000,000 of the Closing Surviving Corporation Cash, $2,000,000 of the Deferred Discount will be due to Jefferies at the Closing, with the remaining $3,635,000 (the “Deferred Cash Obligation”) being due to Jefferies no later than eighteen months following the Closing. For the avoidance of doubt, the Deferred Discount is payable solely to Jefferies and not the other IPO Underwriters, which have waived or indicated to PCCT that they will waive their entitlement to the payment of any deferred underwriting discount. The Company may, at its sole discretion, elect to pay all or any of the Deferred Cash Obligation in shares of NewCo Common Stock (the “Deferred Stock Payment Shares”); provided that, the Company will provide Jefferies with written notice of its election to deliver the Deferred Cash Obligation as the Deferred Stock Payment Shares no earlier than sixty (60) calendar days following the Closing but no later than two business days prior to the delivery of the Deferred Stock Payment Shares. Jefferies is entitled to customary shelf registration rights with respect to the Deferred Stock Payment Shares. the Company has agreed to file a shelf registration statement to register the Deferred Stock Payment Shares within fifteen business days of their delivery. In connection with the business combination, the Company also entered into an agreement (the “Forward Purchase Agreement”) for an OTC Equity Prepaid Forward Transaction (the “Forward Purchase Transaction”) with the Seller. Pursuant to the terms of the Forward Purchase Agreement, the Seller intends, but is not obligated, to purchase up to a maximum of 2,457,892 of Perception’s Class A Ordinary Shares from holders (other than Perception or its affiliates) who have elected to redeem such shares in connection with the Business Combination. Purchases by Seller will be made through brokers in the open market after the redemption deadline in connection with the Business Combination. Following the Closing, and as additional consideration for the Merger, after the occurrence of certain Triggering Events, Acquiror shall issue or cause to be issued to the Eligible Company Equityholders 7,500,000 shares of Acquiror Common Stock (which shall be equitably adjusted for stock splits, reverse stock splits, stock dividends, reorganizations, recapitalizations, reclassifications, combinations, exchanges of shares or other like changes or transactions with respect to Domesticated Acquiror Common Stock occurring on or after the Closing) (such shares, the “Earnout Shares”), upon the terms and subject to the conditions set forth in the Agreement. The Triggering events are (i) the date on which the volume-weighted average closing sale price of one share of Acquiror Common Stock quoted on the Nasdaq Capital Market is greater than or equal to $15.00 for any twenty trading days within any thirty consecutive trading day period within the earnout period, (ii) the date on which the volume-weighted average closing sale price of one share of Acquiror Common Stock quoted on the Nasdaq Capital Market is greater than or equal to $20.00 for any twenty trading days within any thirty consecutive trading day period within the earnout period, or (iii) the date on which the volume-weighted average closing sale price of one share of Acquiror Common Stock quoted on the Nasdaq Capital Market is greater than or equal to $25.00 for any twenty trading days within any thirty consecutive trading day period within the earnout period. The earnout period is the time period between the Closing Date and the five-year

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.	Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates.	Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates.
Cash	Cash The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2023 and December 31, 2022.	Cash The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2022 and 2021.
Investments Held in Trust Account	Investments Held in Trust Account As of March 31, 2023 and December 31, 2022, the assets held in the Trust Account were comprised of U.S. government securities, within the meaning set forth in Section 2(a) (16) of the Investment Company Act, with maturities of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are reported in the statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. As of March 31, 2023 and December 31, 2022, the assets held in the Trust Account were held in money market funds, which were invested in U.S. Treasury securities. The Company had $26,071,412 and $25,517,987 in investments held in the Trust Account as of March 31, 2023 and December 31, 2022, respectively.	Investments Held in Trust Account As of December 31, 2022 and 2021, the assets held in the Trust Account were comprised of U.S. government securities, within the meaning set forth in Section 2(a) (16) of the Investment Company Act, with maturities of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are reported in the statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. As of December 31, 2022 and December 31, 2021, the assets held in the Trust Account were held in money market funds, which were invested in U.S. Treasury securities. The Company had $25,517,987 and $233,452,747 in investments held in the Trust Account as of December 31, 2022 and December 31, 2021, respectively.
Warrants	Warrants The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in non-cash	Warrants The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC Topic 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in non-cash
Ordinary Shares Subject To Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption All of the 23,000,000 Class A ordinary shares sold as part of the Units in the Initial Public Offering contain a redemption feature which allows for the redemption, at a price of $10.15 per share, of such Public Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Amended and Restated Memorandum and Articles of Association. In accordance with ASC 480-10-S99, Under ASC 480, the Company has elected to recognize changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid-in As of March 31, 2023 and December 31, 2022, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table: Gross proceeds $ 230,000,000 Less: Proceeds allocated to Public Warrants (9,637,000 ) Issuance costs allocated to Class A ordinary shares (12,907,420 ) Plus: Accretion of carrying value to redemption value 28,124,181 Initial Pre-Extension (210,161,774 ) Class A ordinary shares subject to possible redemption as of December 31, 2022 25,417,987 Plus: Remeasurement of carrying value to redemption value 553,425 Class A ordinary shares subject to possible redemption as of March 31, 2023 $ 25,971,412	Class A Ordinary Shares Subject to Possible Redemption All of the 23,000,000 Class A ordinary shares sold as part of the Units in the Initial Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Amended and Restated Memorandum and Articles of Association. In accordance with ASC 480-10-S99, Under ASC 480, the Company has elected to recognize changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid-in As of December 31, 2022 and December 31, 2021, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table: Gross proceeds $ 230,000,000 Less: Proceeds allocated to Public Warrants (9,637,000 ) Issuance costs allocated to Class A ordinary shares (12,907,420 ) Plus: Accretion of carrying value to redemption value 25,994,420 Class A ordinary shares subject to possible redemption as of December 31, 2021 233,450,000 Plus: Remeasurement of carrying value to redemption value 2,129,761 Initial Pre-Extension (210,161,774 ) Class A ordinary shares subject to possible redemption as of December 31, 2022 $ 25,417,987
Offering Costs associated with the Initial Public Offering	Offering Costs associated with the Initial Public Offering The Company complies with the requirements of ASC Topic 340, Other Assets and Deferred Costs	Offering Costs associated with the Initial Public Offering The Company complies with the requirements of ASC Topic 340, Other Assets and Deferred Costs Expenses of Offering
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC Topic 740, Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2023 and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC Topic 740, Income Taxes (“ASC 740”). Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Loss Per Ordinary Share	Net Loss Per Ordinary Share Net loss per ordinary share is computed by dividing net loss by the weighted-average number of ordinary shares outstanding during the period. Accretion associated with the redeemable Class A ordinary shares is excluded from net loss per share as the redemption value approximates fair value. Therefore, the earnings per share calculation allocates income and losses shared pro rata between Class A and Class B ordinary shares. As a result, the calculated net loss per share is the same for Class A and Class B ordinary shares. The Company has not considered the effect of the Public Warrants and Private Placement Warrants to purchase an aggregate of 21,550,000 shares in the calculation of diluted net loss per share, since the exercise of the warrants are contingent upon the occurrence of future events. The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts): For the three months ended March 31, 2023 For the three months ended March 31, 2022 Class A Class B Class A Class B Basic and diluted net loss per share: Numerator: Net loss $ (611,882 ) $ (1,431,440 ) $ (392,143 ) $ (98,036 ) Denominator: Basic and diluted weighted average shares 2,457,892 5,750,000 23,000,000 5,750,000 Basic and diluted net loss per share $ (0.25 ) $ (0.25 ) $ (0.02 ) $ (0.02 )	Net Loss Per Ordinary Share Net loss per ordinary share is computed by dividing net loss by the weighted-average number of ordinary shares outstanding during the period. Accretion associated with the redeemable Class A ordinary shares is excluded from net loss per share as the redemption value approximates fair value. Therefore, the earnings per share calculation allocates income and losses shared pro rata between Class A and Class B ordinary shares. As a result, the calculated net loss per share is the same for Class A and Class B ordinary shares. The Company has not considered the effect of the Public Warrants and Private Placement Warrants to purchase an aggregate of 21,550,000 shares in the calculation of diluted net loss per share, since the exercise of the warrants are contingent upon the occurrence of future events. The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts): For the Period Ended For the Period January 21, 2021 (Inception) through December 31, 2021 Class A Class B Class A Class B Basic and diluted net loss per share: Numerator: Net loss $ (1,360,510 ) $ (403,283 ) $ (138,342 ) $ (174,932 ) Denominator: Basic and diluted weighted average shares 19,398,096 5,750,000 4,011,628 5,072,674 Basic and diluted net loss per share $ (0.07 ) $ (0.07 ) $ (0.03 ) $ (0.03 )
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company applies ASC Topic 820, Fair Value Measurement reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. The carrying amounts reflected in the balance sheet for current assets and current liabilities approximate fair value due to their short-term nature. Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. See Note 9 for additional information on assets and liabilities measured at fair value.	Fair Value of Financial Instruments The Company applies ASC Topic 820, Fair Value Measurement The carrying amounts reflected in the balance sheet for current assets and current liabilities approximate fair value due to their short-term nature. Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. See Note 8 for additional information on assets and liabilities measured at fair value.
Recent Accounting Standards	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Reconciliation of Ordinary Shares Subject to Possible Redemption	As of March 31, 2023 and December 31, 2022, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table: Gross proceeds $ 230,000,000 Less: Proceeds allocated to Public Warrants (9,637,000 ) Issuance costs allocated to Class A ordinary shares (12,907,420 ) Plus: Accretion of carrying value to redemption value 28,124,181 Initial Pre-Extension (210,161,774 ) Class A ordinary shares subject to possible redemption as of December 31, 2022 25,417,987 Plus: Remeasurement of carrying value to redemption value 553,425 Class A ordinary shares subject to possible redemption as of March 31, 2023 $ 25,971,412	As of December 31, 2022 and December 31, 2021, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table: Gross proceeds $ 230,000,000 Less: Proceeds allocated to Public Warrants (9,637,000 ) Issuance costs allocated to Class A ordinary shares (12,907,420 ) Plus: Accretion of carrying value to redemption value 25,994,420 Class A ordinary shares subject to possible redemption as of December 31, 2021 233,450,000 Plus: Remeasurement of carrying value to redemption value 2,129,761 Initial Pre-Extension (210,161,774 ) Class A ordinary shares subject to possible redemption as of December 31, 2022 $ 25,417,987
Calculation of Basic and Diluted Net Loss Per Ordinary Share	The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts): For the three months ended March 31, 2023 For the three months ended March 31, 2022 Class A Class B Class A Class B Basic and diluted net loss per share: Numerator: Net loss $ (611,882 ) $ (1,431,440 ) $ (392,143 ) $ (98,036 ) Denominator: Basic and diluted weighted average shares 2,457,892 5,750,000 23,000,000 5,750,000 Basic and diluted net loss per share $ (0.25 ) $ (0.25 ) $ (0.02 ) $ (0.02 )	The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts): For the Period Ended For the Period January 21, 2021 (Inception) through December 31, 2021 Class A Class B Class A Class B Basic and diluted net loss per share: Numerator: Net loss $ (1,360,510 ) $ (403,283 ) $ (138,342 ) $ (174,932 ) Denominator: Basic and diluted weighted average shares 19,398,096 5,750,000 4,011,628 5,072,674 Basic and diluted net loss per share $ (0.07 ) $ (0.07 ) $ (0.03 ) $ (0.03 )

Accrued Expenses (Tables)

Accrued Expenses (Tables)	3 Months Ended
	Mar. 31, 2023
Accounts Payable And Accrued Liabilities Current [Abstract]
Schedule of Accrued Expenses	Accrued expenses consisted of the following at the dates indicated: March 31, December 31, Accrued expenses: Accrued legal fees $ 3,581,322 $ 1,905,225 Accrued accounting fees 133,341 1,600 Total accrued expenses $ 3,714,663 $ 1,906,825

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Financial Assets Measured at Fair Value on a Recurring Basis	The following table presents information about the Company’s financial assets that are measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Amount at Level 1 Level 2 Level 3 March 31, 2023 Assets Investments held in Trust Account: U.S. Treasury Securities $ 26,071,412 $ 26,071,412 $ — $ — Liabilities Forward purchase units $ 4,020,000 $ — $ — $ 4,020,000 December 31, 2022 Assets Investments held in Trust Account: U.S. Treasury Securities $ 25,517,987 $ 25,517,987 $ — $ —	The following table presents information about the Company’s financial assets that are measured at fair value on a recurring basis as of December 31, 2022 and December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Amount at Fair Value Level 1 Level 2 Level 3 December 31, 2022 Assets Investments held in Trust Account: U.S. Treasury Securities $ 25,517,987 $ 25,517,987 $ — $ — December 31, 2021 Assets Investments held in Trust Account: U.S. Treasury Securities $ 233,452,747 $ 233,452,747 $ — $ —
Schedule of Significant Inputs Model For The Fair Value of Forward Purchase Units	The following table provides the significant inputs to the model for the fair value of the forward purchase units: At (inception) At March 31, 2023 Equity value $ 10.75 $ 10.63 Strike Price $ 11.93 $ 11.93 Remaining Life (years) 1.80 1.59 Risk-free rate 4.70 % 4.60 % Volatility 52.90 % 56.90 %
Schedule of Changes in The Fair Value of Level 3 Financial Instruments	The following table presents the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value: Level 3 Fair value as of January 14, 2023 (inception) $ 3,830,000 Change in fair value of forward purchase units 190,000 Fair value as of March 31, 2023 $ 4,020,000

Description of Organization, _2

Description of Organization, Business Operations and Liquidity - Additional Information (Detail)						3 Months Ended		11 Months Ended	12 Months Ended
	Jan. 16, 2023 d $ / shares shares	Oct. 28, 2022 USD ($) $ / shares shares	Oct. 28, 2022 USD ($) $ / shares shares	Aug. 16, 2022	Nov. 01, 2021 USD ($) $ / shares shares	Mar. 31, 2023 USD ($) $ / shares shares	Mar. 31, 2022 USD ($)	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Mar. 23, 2023 shares	Oct. 31, 2022 USD ($)	Sep. 29, 2022 shares	Aug. 31, 2021 shares	Jan. 25, 2021 USD ($)
Organization Consolidation and Presentation of Financial Statements [Line Items]
Minimum net worth to consummate business combination									$ 5,000,001
Percentage of excise tax				1%
Proceeds from initial public offering gross								$ 225,400,000
Proceeds from sale of private placement warrants								10,050,000
Deferred underwriting fees						$ 5,635,000		8,050,000	$ 8,050,000
Restricted from redeeming maximum percentage of public shares, without prior consent						15%			15%
Percentage of public shares that would not be redeemed if business combination is not completed within initial combination period						100%			100%
Percentage of public shares, at-per share price, payable in cash						100%			100%
Expenses payable on dissolution						$ 100,000			$ 100,000
Value per public share in the trust account | $ / shares						$ 10.15			$ 10.15
Ordinary shares, shares outstanding | shares		23,264,839	23,264,839									28,750,000
Ordinary shares, percentage of voting power		80.90%	80.90%
Ordinary shares, shares issued | shares												28,750,000
Payments of stock issuance costs							$ 7,000	$ 613,329
Preference shares, par value | $ / shares						$ 0.0001		$ 0.0001	$ 0.0001
Cash held outside the trust account						$ 48,857			$ 4,730
Working capital deficit						9,566,369			$ 3,139,622
Merger Agreement
Organization Consolidation and Presentation of Financial Statements [Line Items]
Ordinary shares, shares issued | shares	7,500,000
Date Of Agreement	Jan. 16, 2023								Jan. 16, 2023
Conversion of stock, description	prior to the effective time of the Business Combination (the “Effective Time”), the aggregate amount of each outstanding convertible promissory note of Spectaire, including all outstanding principal and interest accrued but unpaid thereon, will convert into shares of common stock, par value $0.0001 per share, of Spectaire (“Spectaire Common Stock”), and each share of the Series Seed Preferred Stock, par value $0.0001 per share, of Spectaire will convert into one share of Spectaire Common Stock (such conversions, the “Spectaire Security Conversion”);
Number of trading days | d	20
Number of consecutive trading days | d	30
Earnout period	5 years
Extension Loan
Organization Consolidation and Presentation of Financial Statements [Line Items]
Outstanding amount of debt						491,578			$ 196,631		$ 196,631
Promissory Note | Merger Agreement
Organization Consolidation and Presentation of Financial Statements [Line Items]
Aggregate principal amount						500,000
Drawdowns on debt						0
Quoted Price Greater Than or Equal to 15 | Merger Agreement
Organization Consolidation and Presentation of Financial Statements [Line Items]
Ordinary shares, shares issued | shares	2,500,000
Quoted Price Greater Than or Equal to 20 | Merger Agreement
Organization Consolidation and Presentation of Financial Statements [Line Items]
Ordinary shares, shares issued | shares	5,000,000
Quoted Price Greater Than or Equal to 25 | Merger Agreement
Organization Consolidation and Presentation of Financial Statements [Line Items]
Ordinary shares, shares issued | shares	7,500,000
Quoted Price Less Than 15 | Merger Agreement
Organization Consolidation and Presentation of Financial Statements [Line Items]
Ordinary shares, shares issued | shares	0
IPO
Organization Consolidation and Presentation of Financial Statements [Line Items]
Units issued during the period shares | shares					23,000,000
Proceeds from initial public offering gross					$ 230,000,000
Transaction costs related to the issuances						13,617,198			13,617,198
Cash underwriting fees						4,600,000			4,600,000
Deferred underwriting fees						8,050,000			8,050,000
Other offering cost						$ 967,198			967,198
Over-Allotment Option
Organization Consolidation and Presentation of Financial Statements [Line Items]
Units issued during the period shares | shares					3,000,000
Proceeds from initial public offering gross					$ 30,000,000
Sponsor
Organization Consolidation and Presentation of Financial Statements [Line Items]
Investment of cash in trust account					$ 233,450,000
Cash deposited in trust account per unit | $ / shares					$ 10.15
Term of restricted investments					185 days
Ordinary shares, shares outstanding | shares													5,750,000
Sponsor | Promissory Note
Organization Consolidation and Presentation of Financial Statements [Line Items]
Aggregate principal amount														$ 300,000
Outstanding amount of debt					$ 223,765			$ 0	$ 0
Sponsor | Over-Allotment Option
Organization Consolidation and Presentation of Financial Statements [Line Items]
Units issued during the period shares | shares					1,050,000
Sponsor | Private Placement
Organization Consolidation and Presentation of Financial Statements [Line Items]
Units issued during the period shares | shares					10,050,000
Unit price per share | $ / shares					$ 1
Proceeds from sale of private placement warrants					$ 10,050,000
Class A Ordinary Shares
Organization Consolidation and Presentation of Financial Statements [Line Items]
Ordinary shares, shares outstanding | shares		17,514,839	17,514,839			0		0	0			23,000,000
Ordinary shares, par value | $ / shares		$ 0.0001	$ 0.0001			$ 0.0001		$ 0.0001	$ 0.0001
Ordinary shares, shares issued | shares						0		0	0			23,000,000
Temporary equity, shares subject to possible redemption | shares						2,457,892		23,000,000	2,457,892	2,457,892
Class A Ordinary Shares | Merger Agreement
Organization Consolidation and Presentation of Financial Statements [Line Items]
Temporary equity, shares subject to possible redemption | shares	2,457,892
Class A Ordinary Shares | Shares Subject to Possible Redemption
Organization Consolidation and Presentation of Financial Statements [Line Items]
Ordinary shares, shares outstanding | shares						2,457,892		23,000,000	2,457,892
Ordinary shares, shares issued | shares						2,457,892		23,000,000	2,457,892
Temporary equity, shares subject to possible redemption | shares		20,542,108	20,542,108			23,000,000			23,000,000
Temporary equity shares issues and outstanding percentage		89.30%	89.30%
Payments of stock issuance costs		$ 210,161,773.71	$ 210,161,773.71
Redemption price per share | $ / shares		$ 10.23	$ 10.23			$ 10.15
Class B Ordinary Shares
Organization Consolidation and Presentation of Financial Statements [Line Items]
Ordinary shares, shares outstanding | shares		5,750,000	5,750,000			5,750,000		5,750,000	5,750,000			5,750,000	5,750,000
Ordinary shares, par value | $ / shares		$ 0.0001	$ 0.0001			$ 0.0001		$ 0.0001	$ 0.0001
Ordinary shares, shares issued | shares						5,750,000		5,750,000	5,750,000			5,750,000
Class B Ordinary Shares | Sponsor
Organization Consolidation and Presentation of Financial Statements [Line Items]
Ordinary shares, shares outstanding | shares													5,750,000
Series Seed Preferred Stock | Merger Agreement
Organization Consolidation and Presentation of Financial Statements [Line Items]
Preference shares, par value | $ / shares	$ 0.0001
Spectaire Common Stock | Merger Agreement
Organization Consolidation and Presentation of Financial Statements [Line Items]
Ordinary shares, par value | $ / shares	0.0001
Minimum
Organization Consolidation and Presentation of Financial Statements [Line Items]
Fair market value as percentage of net assets held in trust account included in initial business combination						80%			80%
Post-transaction ownership percentage of the target entity						50%			50%
Value per share to be maintained in the trust account | $ / shares						$ 10.15			$ 10.15
Maximum | Quoted Price Greater Than or Equal to 15 | Merger Agreement
Organization Consolidation and Presentation of Financial Statements [Line Items]
Weighted average closing sale price per share | $ / shares	15
Maximum | Quoted Price Greater Than or Equal to 20 | Merger Agreement
Organization Consolidation and Presentation of Financial Statements [Line Items]
Weighted average closing sale price per share | $ / shares	20
Maximum | Quoted Price Greater Than or Equal to 25 | Merger Agreement
Organization Consolidation and Presentation of Financial Statements [Line Items]
Weighted average closing sale price per share | $ / shares	$ 25
Maximum | Sponsor | Convertible Promissory Note
Organization Consolidation and Presentation of Financial Statements [Line Items]
Aggregate principal amount											$ 720,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)				3 Months Ended	11 Months Ended	12 Months Ended
	Mar. 23, 2023	Mar. 22, 2023	Nov. 01, 2021	Mar. 31, 2023	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Oct. 28, 2022
Summary Of Significant Accounting Policies [Line Items]
Maximum maturity period of investments held in trust account						185 days	185 days
Cash equivalents				$ 0	$ 0	$ 0	$ 0
Investments held in Trust Account				26,071,412	233,452,747	25,517,987	233,452,747
Re-measurement of carrying value to redemption value				553,425	25,994,420	2,129,761
Expenses payable on dissolution				100,000		100,000
Deferred offering costs				14,532
Unrecognized tax benefits				0	0	0	0
Accrued for interest and penalties				0	$ 0	0	$ 0
Federal depository insurance coverage				$ 250,000		$ 250,000
Public Warrants and Private Placement Warrants
Summary Of Significant Accounting Policies [Line Items]
Antidilutive securities excluded from computation of net income (loss) per share, amount				21,550,000		21,550,000
IPO
Summary Of Significant Accounting Policies [Line Items]
Deferred offering costs			$ 13,507,794
Cash underwriting fees			4,600,000
Deferred underwriting fees			8,050,000
Other offering costs			857,794
Offering costs, reduction of temporary equity			12,907,420
Offering costs, reduction of permanent equity			$ 600,374
Deferred underwriting discount	$ 5,635,000	$ 8,050,000
Class A Ordinary Shares
Summary Of Significant Accounting Policies [Line Items]
Temporary equity, shares subject to possible redemption	2,457,892			2,457,892	23,000,000	2,457,892	23,000,000
Class A Ordinary Shares | Shares Subject to Possible Redemption
Summary Of Significant Accounting Policies [Line Items]
Temporary equity, shares subject to possible redemption				23,000,000		23,000,000		20,542,108
Redemption price per share				$ 10.15				$ 10.23
Re-measurement of carrying value to redemption value				$ 553,425		$ 2,129,761

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Reconciliation of Ordinary Shares Subject to Possible Redemption (Details) - USD ($)	3 Months Ended		11 Months Ended	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Temporary Equity [Line Items]
Less: Issuance costs allocated to Class A ordinary shares		$ (7,000)	$ (613,329)
Re-measurement of carrying value to redemption value	$ 553,425		25,994,420	$ 2,129,761
Ordinary shares subject to possible redemption	25,971,412		233,450,000	25,417,987	$ 233,450,000
Class A Ordinary Shares | Securities Subject to Mandatory Redemption
Temporary Equity [Line Items]
Gross proceeds				230,000,000	230,000,000
Less: Proceeds allocated to Public Warrants				(9,637,000)	(9,637,000)
Less: Issuance costs allocated to Class A ordinary shares				(12,907,420)	(12,907,420)
Accretion of carrying value to redemption value				28,124,181	25,994,420
Re-measurement of carrying value to redemption value	553,425			2,129,761
Initial Pre-Extension Redemption				(210,161,774)
Ordinary shares subject to possible redemption	$ 25,971,412		$ 233,450,000	$ 25,417,987	$ 233,450,000

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Calculation of Basic and Diluted Net Loss Per Ordinary Share (Details) - USD ($)	3 Months Ended		11 Months Ended	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Numerator:
Net loss	$ (2,043,322)	$ (490,179)	$ (313,274)	$ (1,763,793)
Class A Ordinary Shares
Numerator:
Net loss	$ (611,882)	$ (392,143)		$ (1,360,510)	$ (138,342)
Denominator:
Weighted average shares outstanding, Basic	2,457,892	23,000,000	4,011,628	19,398,096	4,011,628
Weighted average shares outstanding, Diluted	2,457,892	23,000,000	4,011,628	19,398,096
Net income (loss) per share, Basic	$ (0.25)	$ (0.02)	$ (0.03)	$ (0.07)	$ (0.03)
Net Income (loss) per share, Diluted	$ (0.25)	$ (0.02)	$ (0.03)	$ (0.07)
Class B Ordinary Shares
Numerator:
Net loss	$ (1,431,440)	$ (98,036)		$ (403,283)	$ (174,932)
Denominator:
Weighted average shares outstanding, Basic	5,750,000	5,750,000	5,072,674	5,750,000	5,072,674
Weighted average shares outstanding, Diluted	5,750,000	5,750,000	5,072,674	5,750,000
Net income (loss) per share, Basic	$ (0.25)	$ (0.02)	$ (0.03)	$ (0.07)	$ (0.03)
Net Income (loss) per share, Diluted	$ (0.25)	$ (0.02)	$ (0.03)	$ (0.07)

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Details) - USD ($)		3 Months Ended	11 Months Ended	12 Months Ended
	Nov. 01, 2021	Mar. 31, 2023	Dec. 31, 2021	Dec. 31, 2022
Subsidiary Sale Of Stock [Line Items]
Proceeds from initial public offering gross			$ 225,400,000
IPO
Subsidiary Sale Of Stock [Line Items]
Units issued during the period shares	23,000,000
Proceeds from initial public offering gross	$ 230,000,000
Units issued description		Each Unit consisted of one Class A ordinary share and one-half of one redeemable warrant (“Public Warrant”).		Each Unit consisted of one Class A ordinary share and one-half of one redeemable warrant (“Public Warrant”).
Warrant exercisable to purchase one Class A ordinary share price	$ 11.5
Over-Allotment Option
Subsidiary Sale Of Stock [Line Items]
Units issued during the period shares	3,000,000
Proceeds from initial public offering gross	$ 30,000,000
Warrant exercisable to purchase one Class A ordinary share price	$ 10

Private Placement - Additional

Private Placement - Additional Information (Details) - USD ($)	Nov. 02, 2021	Nov. 01, 2021
Private Placement
Subsidiary Sale Of Stock [Line Items]
Sale of warrants	10,050,000
Warrants price	$ 1
Gross proceeds from warrants issue	$ 10,050,000
Private Placement | Class A Ordinary Shares
Subsidiary Sale Of Stock [Line Items]
Warrant exercisable to purchase one Class A ordinary share price	$ 11.5
Over-Allotment Option
Subsidiary Sale Of Stock [Line Items]
Sale of warrants	1,050,000
Warrant exercisable to purchase one Class A ordinary share price		$ 10

Accrued Expenses - Schedule of

Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accrued expenses:
Accrued legal fees	$ 3,581,322	$ 1,905,225
Accrued accounting fees	133,341	1,600
Total accrued expenses	$ 3,714,663	$ 1,906,825	$ 126,644

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)				1 Months Ended	3 Months Ended		11 Months Ended	12 Months Ended
	Nov. 01, 2021	Apr. 07, 2021	Jan. 25, 2021	Aug. 31, 2021	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Oct. 31, 2022	Oct. 28, 2022	Sep. 29, 2022
Related Party Transaction [Line Items]
Ordinary shares, shares outstanding										23,264,839	28,750,000
Accounts payable - related party					$ 35,425		$ 49,182	$ 104,808
Reimbursed Expenses- Related Party
Related Party Transaction [Line Items]
Related party transaction accrued expenses incurred					15,425	$ 47,652	29,182	316,861
Accounts payable - related party					15,425	25,799	29,182	84,808
Reimbursed Expenses- Related Party
Related Party Transaction [Line Items]
Accounts payable - related party								55,626
Extension Loan
Related Party Transaction [Line Items]
Outstanding amount of debt					491,578			196,631	$ 196,631
Working Capital Loans | Convertible Promissory Note
Related Party Transaction [Line Items]
Outstanding amount of debt					$ 450,000			$ 25,000
Administrative Support Agreement
Related Party Transaction [Line Items]
Related party transaction administration support expenses incurred						$ 30,000
Founder Shares
Related Party Transaction [Line Items]
Stock issued during the period for services value			$ 25,000
Share price		$ 0.003
Number of sale units		90,000
Share-based compensation shares grant date fair value per share					$ 2.08
Share-based compensation shares vested					187,489
Founder Shares | Upon Consummation of Business Combination
Related Party Transaction [Line Items]
Share-based compensation shares grant date fair value per share								$ 2.08
Share-based compensation shares vested								187,489
Founder Shares | Three Independent Directors
Related Party Transaction [Line Items]
Number of sale units		30,000
Sponsor
Related Party Transaction [Line Items]
Stock issued during the period for services value				$ 0
Number of shares surrendered				1,437,500
Ordinary shares, shares outstanding				5,750,000
Sponsor | Promissory Note
Related Party Transaction [Line Items]
Outstanding amount of debt	$ 223,765						0	$ 0
Aggregate principal amount			$ 300,000
Sponsor | Working Capital Loans
Related Party Transaction [Line Items]
Outstanding amount of debt							0	$ 25,000
Debt instrument conversion price per share					$ 1			$ 1
Sponsor | Maximum | Convertible Promissory Note
Related Party Transaction [Line Items]
Aggregate principal amount									$ 720,000
Sponsor | Maximum | Working Capital Loans
Related Party Transaction [Line Items]
Aggregate principal amount					$ 2,500,000			$ 2,500,000
Sponsor | Administrative Support Agreement
Related Party Transaction [Line Items]
Related party transaction administration support expenses incurred							20,000	120,000
Outstanding amount of debt					20,000
Accounts payable - related party							$ 20,000	20,000
Sponsor | Administrative Support Agreement | Maximum
Related Party Transaction [Line Items]
Related party transaction fees payable per month					10,000			10,000
Extension Loan | Convertible Promissory Note
Related Party Transaction [Line Items]
Outstanding amount of debt					$ 491,578			$ 196,631
Class B Ordinary Shares
Related Party Transaction [Line Items]
Ordinary shares, shares outstanding				5,750,000	5,750,000		5,750,000	5,750,000		5,750,000	5,750,000
Class B Ordinary Shares | Founder Shares
Related Party Transaction [Line Items]
Stock issued during the period shares issued for services			7,187,500
Founder shares forfeited during the period	0
Class B Ordinary Shares | Sponsor
Related Party Transaction [Line Items]
Stock issued during the period for services value				$ 0
Number of shares surrendered				1,437,500
Ordinary shares, shares outstanding				5,750,000
Minimum holding period for transfer, assignment or sale of founder shares					1 year			1 year
Class A Ordinary Shares
Related Party Transaction [Line Items]
Ordinary shares, shares outstanding					0		0	0		17,514,839	23,000,000
Class A Ordinary Shares | Extension Loan Warrants
Related Party Transaction [Line Items]
Debt instrument conversion price per share									$ 1
Class A Ordinary Shares | Sponsor
Related Party Transaction [Line Items]
Share price					$ 12			$ 12
Threshold trading days					20 days			20 days
Threshold consecutive trading days					30 days			30 days
Period after initial business combination					150 days			150 days
One Class A Ordinary Share | Extension Loan Warrants
Related Party Transaction [Line Items]
Warrants price									$ 11.5

Commitments - Additional Inform

Commitments - Additional Information (Details) - USD ($)		3 Months Ended	11 Months Ended
	Nov. 01, 2021	Mar. 31, 2023	Dec. 31, 2021
Commitments [Line Items]
Aggregate purchase price			$ 225,400,000
Underwriting Agreement
Commitments [Line Items]
Number of sale units	3,000,000
Offering price	$ 10
Aggregate purchase price	$ 30,000,000
Cash underwriting discount per unit	$ 0.2
Cash underwriting discount	$ 4,600,000
Deferred underwriting commission per unit	$ 0.35
Deferred underwriting commission	$ 8,050,000
Deferred underwriting fees		$ 2,415,000

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Details) - USD ($)					1 Months Ended	3 Months Ended		11 Months Ended	12 Months Ended
	Oct. 28, 2022	Oct. 28, 2022	Aug. 31, 2021	Jan. 25, 2021	Aug. 31, 2021	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Mar. 23, 2023	Sep. 29, 2022
Class Of Stock [Line Items]
Preference shares, shares authorized						5,000,000		5,000,000	5,000,000
Preference shares, par value						$ 0.0001		$ 0.0001	$ 0.0001
Preference shares, shares issued						0		0	0
Preference shares, shares outstanding						0		0	0
Ordinary shares, shares issued											28,750,000
Ordinary shares, shares outstanding	23,264,839	23,264,839									28,750,000
Payments of stock issuance costs							$ 7,000	$ 613,329
Common stock, conversion basis						one-for-one basis			one-for-one basis
Percentage of common stock issued and outstanding						20%			20%
Warrant issuance, description						No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. Accordingly, unless you purchase at least two Units, you will not be able to receive or trade a whole warrant.			No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. Accordingly, unless you purchase at least two Units, you will not be able to receive or trade a whole warrant.
Warrants expiration period						5 years			5 years
Warrant redemption period						30 days
Warrants
Class Of Stock [Line Items]
Warrants price						$ 0.01			$ 0.01
Warrant redemption period									30 days
Warrants | IPO
Class Of Stock [Line Items]
Number of warrants issued						21,550,000			21,550,000
Warrants | Public Warrants
Class Of Stock [Line Items]
Number of warrants issued						11,500,000			11,500,000
Warrants | Private Placement
Class Of Stock [Line Items]
Number of warrants issued						10,050,000			10,050,000
Class A Ordinary Shares
Class Of Stock [Line Items]
Ordinary shares, shares authorized						500,000,000		500,000,000	500,000,000
Ordinary shares, par value	$ 0.0001	$ 0.0001				$ 0.0001		$ 0.0001	$ 0.0001
Common stock voting rights						one vote			one vote
Ordinary shares, shares issued						0		0	0		23,000,000
Ordinary shares, shares outstanding	17,514,839	17,514,839				0		0	0		23,000,000
Temporary equity, shares subject to possible redemption						2,457,892		23,000,000	2,457,892	2,457,892
Class A Ordinary Shares | Warrants
Class Of Stock [Line Items]
Warrant redemption period						30 days			30 days
Threshold trading days for redemption of warrants									20 days
Minimum threshold written notice period for redemption of warrants									30 days
Share price						$ 18			$ 18
Class A Ordinary Shares | Shares Subject to Possible Redemption
Class Of Stock [Line Items]
Ordinary shares, shares issued						2,457,892		23,000,000	2,457,892
Ordinary shares, shares outstanding						2,457,892		23,000,000	2,457,892
Temporary equity, shares subject to possible redemption	20,542,108	20,542,108				23,000,000			23,000,000
Payments of stock issuance costs	$ 210,161,773.71	$ 210,161,773.71
Class B Ordinary Shares
Class Of Stock [Line Items]
Preference shares, shares issued									0
Preference shares, shares outstanding								0
Ordinary shares, shares authorized						50,000,000		50,000,000	50,000,000
Ordinary shares, par value	$ 0.0001	$ 0.0001				$ 0.0001		$ 0.0001	$ 0.0001
Common stock voting rights						one vote			one vote
Ordinary shares, shares issued						5,750,000		5,750,000	5,750,000		5,750,000
Ordinary shares, shares outstanding	5,750,000	5,750,000	5,750,000		5,750,000	5,750,000		5,750,000	5,750,000		5,750,000
Class B Ordinary Shares | Sponsor
Class Of Stock [Line Items]
Payments of stock issuance costs				$ 25,000
Exchange for issuance of common stock shares				7,187,500
Number of common stock surrendered			1,437,500		1,437,500

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value on a Recurring Basis (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Forward Purchase Units
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Liabilities, Fair value	$ 4,020,000
U.S. Treasury Securities
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Investments held in trust account, Fair value		$ 25,517,987	$ 233,452,747
Investments held in trust account, Fair value	26,071,412	25,517,987
Level 1 | U.S. Treasury Securities
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Investments held in trust account, Fair value		25,517,987	$ 233,452,747
Investments held in trust account, Fair value	26,071,412	$ 25,517,987
Level 3 | Forward Purchase Units
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Liabilities, Fair value	$ 4,020,000

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Significant Inputs Model For The Fair Value of Forward Purchase Units (Details) - Forward Purchase Units		3 Months Ended
	Jan. 14, 2023 shares	Mar. 31, 2023 shares
Equity value
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Derivative liability measurement input	10.75	10.63
Strike Price
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Derivative liability measurement input	11.93	11.93
Remaining Life (years)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Remaining Life (years)	1 year 9 months 18 days	1 year 7 months 2 days
Risk-free rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Derivative liability measurement input	4.7	4.6
Volatility
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Derivative liability measurement input	52.9	56.9

Fair Value Measurements - Sch_3

Fair Value Measurements - Schedule of Changes in The Fair Value of Level 3 Financial Instruments (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2023
Level 3
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair Value Beginning Balance	$ 3,830,000
Fair value Ending Balance	4,020,000	$ 4,020,000
Forward Purchase Units
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Change in fair value of forward purchase units		$ 190,000
Forward Purchase Units | Level 3
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Change in fair value of forward purchase units	$ 190,000

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details)	3 Months Ended
	Mar. 31, 2023 USD ($)
Forward Purchase Units
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Change in fair value of forward purchase units	$ 190,000

Subsequent Events - Additional

Subsequent Events - Additional Information (Details)

12 Months Ended

May 05, 2023 USD ($) $ / shares

Apr. 27, 2023 USD ($) Numberofholder $ / shares shares

Apr. 03, 2023 USD ($)

Mar. 23, 2023 USD ($) Day $ / shares shares

Mar. 22, 2023 USD ($)

Mar. 06, 2023 USD ($)

Mar. 01, 2023 USD ($)

Feb. 28, 2023 USD ($)

Feb. 01, 2023 USD ($)

Jan. 16, 2023 d $ / shares shares

Jan. 03, 2023 USD ($)

Dec. 31, 2022 $ / shares shares

Apr. 19, 2023 USD ($)

Apr. 10, 2023 USD ($) $ / shares

Apr. 09, 2023 USD ($)

Mar. 31, 2023 USD ($) $ / shares shares

Oct. 31, 2022 USD ($)

Oct. 28, 2022 $ / shares

Sep. 29, 2022 shares

Dec. 31, 2021 $ / shares shares

Jan. 25, 2021 USD ($)

Subsequent Event [Line Items]

Ordinary shares, shares issued | shares

28,750,000

Merger Agreement

Subsequent Event [Line Items]

Date Of Agreement

Jan. 16, 2023

Jan. 16, 2023

Ordinary shares, shares issued | shares

7,500,000

Number of trading days | d

20

Number of consecutive trading days | d

30

Earnout period

5 years

Promissory Note | Merger Agreement

Subsequent Event [Line Items]

Aggregate principal amount

$ 500,000

Drawdowns on debt

$ 0

Sponsor | Convertible Promissory Note | Maximum

Subsequent Event [Line Items]

Aggregate principal amount

$ 720,000

Sponsor | Promissory Note

Subsequent Event [Line Items]

Aggregate principal amount

$ 300,000

Class A Ordinary Shares

Subsequent Event [Line Items]

Ordinary shares, shares issued | shares

0

0

23,000,000

0

Ordinary shares, par value | $ / shares

$ 0.0001

$ 0.0001

$ 0.0001

$ 0.0001

Purchase of shares from holders to redeem shares | shares

2,457,892

2,457,892

2,457,892

23,000,000

Class A Ordinary Shares | Merger Agreement

Subsequent Event [Line Items]

Purchase of shares from holders to redeem shares | shares

2,457,892

Subsequent Event

Subsequent Event [Line Items]

Additional amount drew down on extension loan

$ 98,316

$ 98,316

$ 98,316

Total extension loan

$ 294,947

$ 294,947

$ 294,947

Additional amount drew down on working capital loan

$ 50,000

$ 150,000

$ 225,000

Deferred underwriting discount

$ 5,635,000

Deferred underwriting discount payment due at closing.

2,000,000

Deferred cash obligation to be paid in eighteen months after closing

$ 3,635,000

Ordinary shares, shares issued | shares

7,500,000

Earnout period

5 years

MVLS compliance date

Oct. 02, 2023

MVPHS compliance date

Nov. 01, 2023

Subsequent Event | Maximum

Subsequent Event [Line Items]

Closing surviving corporation cash threshold for payment of deferred underwriting discount

$ 25,000,000

Minimum net worth required for compliance of redemption limitation

$ 5,000,001

Subsequent Event | Minimum

Subsequent Event [Line Items]

Closing surviving corporation cash threshold for payment of deferred underwriting discount

$ 25,000,000

Subsequent Event | Promissory Note | Merger Agreement

Subsequent Event [Line Items]

Drawdowns on debt

$ 200,000

$ 300,000

Subsequent Event | Sponsor | Convertible Promissory Note

Subsequent Event [Line Items]

Aggregate principal amount

$ 1,200,000

$ 720,000

Subsequent Event | Class A Ordinary Shares

Subsequent Event [Line Items]

Ordinary shares, par value | $ / shares

$ 0.0001

Redemption price per share | $ / shares

$ 10.7

Aggregate redemption amount

$ 4,033,654

Purchase of shares from holders to redeem shares | shares

376,977

Number of shareholders, exercised redemption | Numberofholder

17

Minimum MVLS capital requirement for continued listing

$ 50,000,000

Minimum MVPHS capital requirement for continued listing

$ 15,000,000

Subsequent Event | Class A Ordinary Shares | Sponsor

Subsequent Event [Line Items]

Ordinary shares, par value | $ / shares

$ 0.0001

Subsequent Event | Class A Ordinary Shares | Sponsor | Convertible Promissory Note

Subsequent Event [Line Items]

Trust account loan per share | $ / shares

$ 0.04

Quoted Price Greater Than or Equal to 15 | Merger Agreement

Subsequent Event [Line Items]

Ordinary shares, shares issued | shares

2,500,000

Quoted Price Greater Than or Equal to 15 | Maximum | Merger Agreement

Subsequent Event [Line Items]

Weighted average closing sale price per share | $ / shares

$ 15

Quoted Price Greater Than or Equal to 15 | Subsequent Event

Subsequent Event [Line Items]

Number of trading days | Day

20

Number of consecutive trading days | Day

30

Quoted Price Greater Than or Equal to 15 | Subsequent Event | Maximum

Subsequent Event [Line Items]

Weighted average closing sale price per share | $ / shares

$ 15

Quoted Price Greater Than or Equal to 20 | Merger Agreement

Subsequent Event [Line Items]

Ordinary shares, shares issued | shares

5,000,000

Quoted Price Greater Than or Equal to 20 | Maximum | Merger Agreement

Subsequent Event [Line Items]

Weighted average closing sale price per share | $ / shares

$ 20

Quoted Price Greater Than or Equal to 20 | Subsequent Event

Subsequent Event [Line Items]

Number of trading days | Day

20

Number of consecutive trading days | Day

30

Quoted Price Greater Than or Equal to 20 | Subsequent Event | Maximum

Subsequent Event [Line Items]

Weighted average closing sale price per share | $ / shares

$ 20

Quoted Price Greater Than or Equal to 25 | Merger Agreement

Subsequent Event [Line Items]

Ordinary shares, shares issued | shares

7,500,000

Quoted Price Greater Than or Equal to 25 | Maximum | Merger Agreement

Subsequent Event [Line Items]

Weighted average closing sale price per share | $ / shares

$ 25

Quoted Price Greater Than or Equal to 25 | Subsequent Event

Subsequent Event [Line Items]

Number of trading days | Day

20

Number of consecutive trading days | Day

30

Quoted Price Greater Than or Equal to 25 | Subsequent Event | Maximum

Subsequent Event [Line Items]

Weighted average closing sale price per share | $ / shares

$ 25